Global Cord Blood Corporation Files Its Annual Report on Form 20-F

Rhea-AI Summary

Global Cord Blood Corporation (NYSE: CO) has filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission, detailing audited financial statements for the fiscal year ending March 31, 2020. As China's leading cord blood bank, GCBC offers comprehensive services including collection, testing, processing, and storage of stem cells. The Form 20-F is accessible via the SEC's website and GCBC's Investor Relations page. This filing underscores the company's commitment to transparency and regulatory compliance.

Positive

• Filing of Form 20-F indicates compliance with SEC regulations.
• Includes audited financial statements for enhanced credibility.

Negative

• None.

HONG KONG, July 29, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. The filed Form 20-F includes audited financial statements for the fiscal year ended March 31, 2020. The Form 20-F can be accessed by visiting the U.S. Securities and Exchange Commission's website at http://www.sec.gov and also be found at the Investor Relations section of GCBC's website at http://ir.globalcordbloodcorp.com.

About Global Cord Blood Corporation

Global Cord Blood Corporation is the first and largest umbilical cord blood banking operator in China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company's website at:
http://www.globalcordbloodcorp.com.

For more information, please contact:

Global Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@globalcordbloodcorp.com

ICR, Inc.
Mr. William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: William.zima@icrinc.com

 

View original content:http://www.prnewswire.com/news-releases/global-cord-blood-corporation-files-its-annual-report-on-form-20-f-301101882.html

SOURCE Global Cord Blood Corporation

FAQ

What is the significance of Global Cord Blood Corporation's Form 20-F filing?

The Form 20-F filing signifies compliance with SEC regulations and provides audited financial statements, which enhance the company's credibility.

When does the fiscal year end for Global Cord Blood Corporation?

The fiscal year for Global Cord Blood Corporation ends on March 31.

Where can I access Global Cord Blood Corporation's Annual Report?

The Annual Report can be accessed via the SEC's website or the Investor Relations section of GCBC's website.

What services does Global Cord Blood Corporation provide?

Global Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services.

What does the ticker symbol 'CO' represent?

The ticker symbol 'CO' represents Global Cord Blood Corporation on the New York Stock Exchange.